MXCT vs PODD
MaxCyte Inc (MXCT) versus Insulet Corporation (PODD) — a side-by-side from cached financials, not a winner call.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
Insulet Corporation (PODD) is a medical devices company listed on NASDAQ.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
Latest reported PODD revenue for 2024-12-31 was $2.07B. Net income was $418.3M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
MXCT currently screens at market cap $124.3M. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
Not investment advice. Open the MXCT and PODD stock pages for the full models.
Not investment advice.